Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Hovland and Gerard share lead at Tour Championship
-
Kane confirms talks on Bayern extension
-
Maresca salutes 'unbelievable' Cherki after Man City star sinks Palace
-
Trump govt. mulls deal to give away part of Yosemite park
-
Marquinhos rescues last-gasp draw for PSG at Lille in Ligue 1
-
Indian release of Sonia Gandhi memoir uncertain after publisher clarification
-
ICE detains British far-right activist Milo Yiannopoulos in Louisiana
-
Cities show cleaner transport policies can reduce severe air pollution
-
Milo Yiannopoulos held by ICE after missing immigration hearing
-
Four patients harmed in Nashville hospital medication mix-up
-
Six Flags closes X2 rollercoaster after reports of severe brain injuries
-
Essex council hires private guards as Wethersfield asylum centre expands
-
Jury ends second day without verdict in Lindsay Clancy murder trial
-
Haakon VIII becomes Norway's king after Harald V dies at 89
-
Artist says criticised Ronnie O'Sullivan mural is unfinished
-
Six injured after sign falls at Christian festival in West Sussex
-
UAE grants Starlink 10-year satellite broadband licence
-
Dubai airport expands scanners that keep laptops and liquids in bags
-
US says Hormuz mines cleared as diplomacy and military deployments continue
-
Kuwait and Pakistan sign military cooperation agreement
-
Nepal-Tibet flood toll reaches 584 as more than 2,400 remain missing
-
Ramos strikes as AC Milan beat Venezia
-
Cherki makes his point to Maresca as Man City sparkle in Palace rout
-
Odisha faces very heavy rain as Sri Ganganagar reaches 41.4C
-
COP17 soil assessment links worsening land degradation to food and nutrition risks
-
Scammers in China exploit Microsoft Teams and other workplace apps to target victims
-
Medical AI paper predicts autonomous systems could outperform doctors in core clinical tasks by 2030
-
GSA employees report mice, ceiling damage and cloudy water after Washington office move
-
REI Labor Day sale runs through September 7 with outdoor gear discounts
-
Cara and former scraper develop open-source tool to alert artists when work appears in AI datasets
-
Meta tests robots for cabling, server resets and maintenance inside data centers
-
Google expands easier file sharing between Android phones and Apple devices
-
Nepal-Tibet flood rescue resumes after overflowing debris lake forces temporary withdrawal
-
UK chefs turn to induction cooking to reduce kitchen heat, energy use and pollution
-
Extreme heat exposes vulnerabilities across Britain's rail network
-
Restored Cheshire wetland becomes key UK breeding site for black-necked grebes
-
Dollar rallies after Fed chief lifts rate expectations
-
Bayern steamroll Stuttgart in Bundesliga opener
-
Slumping Sabalenka 'confident' ahead of US Open three-peat bid
-
England pace quartet might keep Archer going until he is 40
-
Aston Villa seal swoop for Chelsea striker Jackson
-
Driven by distraction? Trump steps up stunts as US midterms loom
-
Number of missing in deadly Nepal, China floods jumps past 2,400
-
Springboks a wounded beast, warns All Blacks captain Savea
-
Birmingham City Seek First Championship Win Against Wrexham
-
Trump announces new US 'Space Academy'
-
Four-wicket Robinson stars as Pakistan collapse in second Test
-
Best Laser Printers in India: Top Options from HP, Brother and Canon
-
Alcaraz anxious after layoff but feels 'great' about wrist
-
US Monroe Doctrine Revival Risks Pushing Latin America Toward China
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p.m. ET / 4:30 p.m. PT.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
N.Mitchell--AT
